Form D · Biotechnology

Antiva Biosciences, Inc.

Redwood City, CA · CIK 0001563355

Offering snapshot reported Oct 11, 2024 · SEC filing

Reported sold
$38.5M
Offering amount: $53M
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 24, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$19.3M$38.5MMay 5, 2023: $26,565,771.00May 5, 2023Oct 11, 2024: $38,535,985.00Oct 11, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$26,565,771 → $38,535,985

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 11, 2024Amendment$38,535,985$11,970,214vs May 5, 202321SEC filing
May 5, 2023Initial$26,565,771No comparison21SEC filing
Nov 3, 2021Initial$15,639,364No comparison20SEC filing
Jul 19, 2018Initial$15,000,000No comparison8SEC filing
Aug 28, 2017Amendment$14,740,756$3,600,000vs Apr 5, 201715SEC filing
Apr 5, 2017Initial$11,140,756No comparison13SEC filing
Jun 11, 2015Initial$8,907,483No comparison26SEC filing
Dec 23, 2014Initial$1,745,019No comparison19SEC filing
Jul 10, 2014Initial$1,100,000No comparison14SEC filing
Sep 5, 2013Amendment$1,126,006$625,000vs Mar 6, 201318SEC filing
Mar 6, 2013Initial$501,006No comparison6SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-480968

Source: Form D, filed Oct 11, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kristine Ball Director, Executive
Keith Bley Executive
Michael D. Cannon Director
Elaine Chien Executive
Oranee Daniels Executive
Raju Gadiraju Executive
Raju Gadiraju, Ph.D. Executive
Brian Goodman Director
Karl Y. Hostetler Director, Executive
Wendee S. Hutton Director
Wende Hutton Director
Steven James Director
Ting Jia Director
David Kabakoff Director
David Kabakoff, Ph.D. Director
Gail Maderis Director
Vinzenz Ploerer Director
William Respess Director
Benjamin Rovinski Director
Beni Rovinski Director
Clifford Samuel Director
John Sayward Executive
Florencia Segal Director
Michael J. Sullivan Executive
Sarah Walter Executive
Jenny Yip Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
555 Twin Dolphin Drive, Suite 620
Redwood City, CA, 94065